Stavros Stavrakis is a Cardiology physician. ClinicalTrials.gov lists 9 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
920 Stanton L Young Blvd
Wp 1130
Oklahoma City, OK 731045020
Telephone
405-271-5963Registry record last updated 27 Feb 2012.
Clinical trials
- SmartWatch ECG Evaluation Trial I
Sponsor: University of Oklahoma
- Clinical Validation and Safety of the AC 12L ECG System Against a Standard of Care 12-Lead ECG (AC 12L ECG)
Sponsor: University of Oklahoma
- Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
Sponsor: University of Oklahoma
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
19 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Biosense Webster, Inc.Program year202513 payments
- Medtronic, Inc.Program year20254 payments
- Kestra Medical Technology Services, Inc.Program year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
72.1%Antiarrhythmic21.9%Amiodarone Hcl28%Dofetilide23%Multaq21%Flecainide Acetate16%Propafenone Hcl Er13%Part D<11 patientsBeta blocker18.8%Metoprolol Succinate58%Metoprolol Tartrate19%Carvedilol12%Propranolol Hcl10%Part D<11 patients+ 7 more classes in this area
Blood & clotting
24.8%Factor Xa inhibitor24.8%Eliquis80%Xarelto20%Part D<11 patientsMetabolism & gastrointestinal
3.1%SGLT2 inhibitor3.1%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2018–2026 per NIH RePORTER. The latest:
- Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation
University of Oklahoma Hlth Sciences Ctr
FY2026$379,891R01HL161008 - Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation
University of Oklahoma Hlth Sciences Ctr
FY2025$379,891R01HL161008 - Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation
University of Oklahoma Hlth Sciences Ctr
FY2024$379,983R01HL161008
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”